Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-03 4:57 pm Sale | 2021-04-26 | 13D | Aligos Therapeutics, Inc. ALGS | Versant Venture Capital VI, L.P. | 77,757 5.100% | -19,439 (-20.00%) | Filing History |
| 2021-04-08 4:31 pm Purchase | 2021-03-29 | 13D | LAVA Therapeutics N.V. LVTX | Versant Venture Capital VI, L.P. | 3,407,157 13.400% | 3,407,157 (New Position) | Filing History |
| 2021-04-05 4:33 pm Unchanged | 2021-03-26 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.600% | 0 (Unchanged) | Filing History |
| 2021-03-01 5:16 pm Sale | 2021-02-17 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.600% | -325,000 (-12.69%) | Filing History |
| 2021-02-12 8:41 pm Sale | 2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Versant Venture Capital VI, L.P. | 777,727 2.200% | -2,878,858 (-78.73%) | Filing History |